Literature DB >> 6264962

Regulation of cytosol 5'-nucleotidase by adenylate energy charge.

R Itoh.   

Abstract

In the physiological range of the adenylate energy charge in liver (0.7-0.9), th rate of AMP-hydrolysis catalysed by rat liver cytosol 5'-nucleotidase (5'-ribonucleotide phosphohydrolase, EC 3.1.3.5) increased sharply with decreasing energy charge. In addition, a decrease in the concentration of Pi caused marked acceleration of the AMP-hydrolysing activity over the physiological range of adenylate energy charge. These responses seem to serve to protect the cells against a metabolic stress which could result from sudden utilization of ATP by removal of AMP. The AMP-hydrolysing activity of this enzyme decreased sharply as the size of the adenine nucleotide pool decreased in the physiological range. This effect may be a self-limiting response to prevent excess depletion of the pool. IMP-hydrolysing activity of this enzyme increased with increasing adenylate energy charge. But no marked response to its variation within the physiological range was observed. On the basis of the data obtained in this study, the IMP-hydrolysing activity of the cytosol 5'-nucleotidase in rat liver cells seems to be comparable to that of AMP deaminase reaction, but the AMP-hydrolysing activity was estimated to be less than 10% of AMP deaminase reaction at energy charge value of about 0.7. This strongly suggests that the AMP leads to IMP leads to inosine pathway is more significant that the AMP leads to adenosine leads to inosine pathway in rat liver.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264962     DOI: 10.1016/0005-2744(81)90268-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Inhibition of IMP-specific cytosolic 5'-nucleotidase and adenosine formation in rat polymorphonuclear leucocytes by 5'-deoxy-5'-isobutylthio derivatives of adenosine and inosine.

Authors:  A C Skladanowski; G B Sala; A C Newby
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Regulation of rat heart cytosol 5'-nucleotidase by adenylate energy charge.

Authors:  R Itoh; J Oka; H Ozasa
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

3.  Characterization of different molecular forms of 5'-nucleotidase in normal serum and in serum from cholestatic patients and bile-duct-ligated rats.

Authors:  N N Chuang; A C Newby; J P Luzio
Journal:  Biochem J       Date:  1984-12-15       Impact factor: 3.857

4.  5'-Nucleotidase activity and adenosine formation in stimulated, hypoxic and underperfused rat heart.

Authors:  J P Headrick; R J Willis
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

5.  Effect of 5'-deoxy-5'-isobutylthioadenosine on formation and release of adenosine from neonatal and adult rat ventricular myocytes.

Authors:  P Meghji; A C Skladanowski; A C Newby; L L Slakey; J D Pearson
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

6.  Partial purification and properties of an AMP-specific soluble 5'-nucleotidase from pigeon heart.

Authors:  A C Skladanowski; A C Newby
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

7.  Nucleoside exchange catalysed by the cytoplasmic 5'-nucleotidase.

Authors:  Y Worku; A C Newby
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

8.  In vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor.

Authors:  Alexander Choukèr; Akio Ohta; André Martignoni; Dmitriy Lukashev; Lefteris C Zacharia; Edwin K Jackson; Jürgen Schnermann; Jerrold M Ward; Ines Kaufmann; Brenda Klaunberg; Michail V Sitkovsky; Manfred Thiel
Journal:  Transplantation       Date:  2012-11-15       Impact factor: 4.939

9.  Nucleotide catabolism and nucleoside cycles in human thymocytes. Role of orthophosphate.

Authors:  J Barankiewicz; A Cohen
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

10.  Oligomeric interface modulation causes misregulation of purine 5´-nucleotidase in relapsed leukemia.

Authors:  Aleš Hnízda; Jana Škerlová; Milan Fábry; Petr Pachl; Martina Šinalová; Lukáš Vrzal; Petr Man; Petr Novák; Pavlína Řezáčová; Václav Veverka
Journal:  BMC Biol       Date:  2016-10-19       Impact factor: 7.431

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.